Announcement on Resolutions of the 9th Meeting of the 9th Board of Supervisors
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2020-004
Zhejiang Jianfeng Group Co., Ltd.
Announcement of Resolutions of the 9th Session of the 9th Board of Supervisors
The Board of Supervisors and all supervisors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
Meeting of the 1. Board of Supervisors
(I) The convening and convening of this meeting of the Board of Supervisors complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2020 4 January 13 , the company issued the notice of the meeting of the board of supervisors by fax, e-mail and personal delivery.
(III) 2020 4 24 , this board of supervisors meeting was held in the conference room on the third floor of Jianfeng Building, Jinhua City, Zhejiang Province.
(IV) 5 supervisors to be present at this board of supervisors, all supervisors attended this meeting , with 5 valid votes.
(V) This meeting was presided over by Mr. Chen Tianci, Chairman of the Board of Supervisors.
2. Board of Supervisors Meeting Deliberations
1 , Passed the Company's "2019 Annual Board of Supervisors Report"
Meeting After deliberation and voting, the proposal was passed.
voting result: 5 votes in favor, 0 votes against, 0 abstentions
meeting considered that the report fully reflected the work of the board of supervisors in 2019 , and this proposal should be submitted to the shareholders' meeting for deliberation.
2 , passed the "2019 annual financial report"
meeting after deliberation and voting, passed the bill.
voting result: 5 votes in favor, 0 votes against, 0 abstention
this proposal needs to be submitted to the shareholders' meeting for deliberation.
3 , passed the "2019 annual profit distribution plan"
meeting after deliberation and voting, passed the bill. Agree to submit to the general meeting of shareholders for consideration.
The Board of Supervisors believes that: the company's profit distribution plan for 2019 complies with the relevant provisions of the Articles of Association; the description of the profit distribution plan is objective and true, the decision-making procedures are in compliance, and meet the interests of all shareholders and the company's production and operation needs; no discovery The company's profit distribution and cash dividend decisions damage the legitimate rights and interests of shareholders.
Voting Results: 5 Votes Yes, 0 Votes No, 0 Abstentions
The plan will be submitted to the shareholders' meeting for deliberation.
4 , passed the "Proposal on Daily Related Party Transactions of the Company in 2020 "
After deliberation and voting, the proposal was passed.
Voting Results: 5 votes in favor, 0 votes against, 0 abstention
5 , passed the company's "2019 Annual Report and Its Summary"
Meeting passed the bill after deliberation and voting. The Board of Supervisors believes that:
(1 ) annual report preparation and review procedures comply with laws, regulations, the company's articles of association and the company's internal management system;
(2 ) annual report content and format comply with China Various regulations of the Securities Regulatory Commission and the stock exchange, the information contained is true, accurate and complete to reflect the company's 2019 year management and financial status and other matters;
(3 ) did not find that the personnel involved in the preparation and review of the annual report violated the confidentiality provisions.
voting results: 5 votes in favor, 0 votes against, 0 abstentions
This proposal needs to be submitted to the shareholders' meeting for deliberation.
6 and passed the "2020 First Quarter Report"
The Board of Supervisors confirmed that the preparation and review procedures of the "2020 First Quarter Report" comply with laws, regulations and regulatory authorities Relevant regulations, the content truly, accurately and completely reflect the actual situation of the company.
voting results: 5 votes in favor, 0 votes against, 0 abstentions
7 , passed the "2019 Annual Internal Control Evaluation Report"
meeting after deliberation and voting, passed the bill.
Voting Results: 5 Votes Agree, 0 Votes Against, 0 Abstentions
3. Relevant Annex
Company's 9th 162 Meeting Resolution
This is to announceZhejiang Jianfeng Group Co., Ltd.
Board of Supervisors
April 28, 2020
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page